RASD2 and thyroid cancer: While we focused on RASD2 as a target of miRNA‐485‐5p, future studies should investigate other downstream targets of miRNA‐485‐5p that may also contribute to thyroid cancer progression, providing a more complete understanding of miRNA‐485‐5p's role in this disease.